Boehringer Ingelheim Pharma GmbH & Co. KG (unpacked product, primary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of multiple sclerosis (relapsing-remitting and secondary progressive forms), as well as for isolated clinical manifestations that provide grounds to suspect this disease.
Dosage form: powder, lyophilized for injection solution
Active substance Dosage interferon beta-1b 0.3 mg (9.6 million IU) ATC: L03AB08